Pituitary adenoma,Craniopharyngioma,Chordoma,Tuberculum sellae meningioma
Conditions
Interventions
Experimental Group:Surgery using a 4K fluorescent endoscope
Control group:Standard 4K Endoscope (without Fluorescence Module)
Sponsors
The first affiliated hostipal of nanchang university
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Aged >= 18 and <75 years. 2.Patients with tumors requiring surgical resection via craniotomy (e.g., meningioma, glioma, schwannoma) or via endoscopic endonasal approach (e.g., pituitary adenoma, craniopharyngioma, chordoma, tuberculum sellae meningioma). 3.Patient provides written informed consent to participate in the trial.
Exclusion criteria
Exclusion criteria: 1.Presence of surgical contraindications, such as severe coagulation disorders; 2.Patient refusal of surgery; 3.Patient being in menstruation, pregnancy, or lactation on the day of surgery; 4.Administration of anticoagulant or antiplatelet medications within 1 month prior to surgery; 5.Deemed by the clinician to be otherwise unsuitable for the surgery;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative MRI was used to assess the gross total resection rate ;The preservation of neurological function; | — |
Secondary
| Measure | Time frame |
|---|---|
| In malignant tumors such as glioma, the concordance between definitive fluorescent im; | — |
Countries
China
Contacts
Public ContactBin tang
The first affiliated hostipal of nanchang university
Outcome results
None listed